rs149055334

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_018100.4(EFHC1):​c.229C>A​(p.Pro77Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0013 in 1,614,090 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0072 ( 21 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 12 hom. )

Consequence

EFHC1
NM_018100.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 0.485
Variant links:
Genes affected
EFHC1 (HGNC:16406): (EF-hand domain containing 1) This gene encodes an EF-hand-containing calcium binding protein. The encoded protein likely plays a role in calcium homeostasis. Mutations in this gene have been associated with susceptibility to juvenile myoclonic epilepsy and juvenile absence epilepsy. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00282076).
BP6
Variant 6-52424111-C-A is Benign according to our data. Variant chr6-52424111-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 205400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00719 (1095/152218) while in subpopulation AFR AF= 0.0249 (1032/41528). AF 95% confidence interval is 0.0236. There are 21 homozygotes in gnomad4. There are 510 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1095 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
EFHC1NM_018100.4 linkuse as main transcriptc.229C>A p.Pro77Thr missense_variant 2/11 ENST00000371068.11
EFHC1NM_001172420.2 linkuse as main transcriptc.172C>A p.Pro58Thr missense_variant 3/12
EFHC1NR_033327.2 linkuse as main transcriptn.298C>A non_coding_transcript_exon_variant 2/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
EFHC1ENST00000371068.11 linkuse as main transcriptc.229C>A p.Pro77Thr missense_variant 2/111 NM_018100.4 P1Q5JVL4-1

Frequencies

GnomAD3 genomes
AF:
0.00721
AC:
1096
AN:
152100
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0249
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00194
AC:
488
AN:
251438
Hom.:
7
AF XY:
0.00159
AC XY:
216
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.0255
Gnomad AMR exome
AF:
0.00173
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000703
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000690
AC:
1008
AN:
1461872
Hom.:
12
Cov.:
33
AF XY:
0.000620
AC XY:
451
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.0243
Gnomad4 AMR exome
AF:
0.00188
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000189
Gnomad4 OTH exome
AF:
0.00141
GnomAD4 genome
AF:
0.00719
AC:
1095
AN:
152218
Hom.:
21
Cov.:
32
AF XY:
0.00685
AC XY:
510
AN XY:
74416
show subpopulations
Gnomad4 AFR
AF:
0.0249
Gnomad4 AMR
AF:
0.00333
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.00114
Hom.:
4
Bravo
AF:
0.00863
ESP6500AA
AF:
0.0243
AC:
107
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00235
AC:
285
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsSep 30, 2017- -
not provided, no classification providedclinical testingGeneDxApr 03, 2015p.Pro77Thr (CCT>ACT): c.229 C>A in exon 2 of the EFHC1 gene (NM_018100.3). P77T and R221H were identified on the same chromosome and co-segregated with juvenile myoclonic epilepsy (JME) in two families (Suzuki et al., 2004). Functional studies suggest that both P77T and R221H impair apoptosis and alter calcium currents (Suzuki et al., 2004). However, both P77T and R221H have subsequently been identified in 1-3% of the African population in the NHLBI ESP Exome Variant Project and the 1000 Genomes Database. P77T results in a nonconservative amino acid substitution, while the R221H substitution is a conservative change. Both of these missense substitutions alter positions in the protein that are not highly conserved throughout evolution or in related proteins, and multiple in silico models predict they are likely benign. Therefore, currently available evidence suggests that P77T and R221H may be associated with JME, although the possibility that they are benign variants cannot be completely excluded. The variant is found in CHILD-EPI,EPILEPSY,INFANT-EPI panel(s). -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsDec 02, 2016- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJun 23, 2020- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 08, 2016- -
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:2
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 22, 2022- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 18, 2024- -
EFHC1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 30, 2021This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
10
DANN
Benign
0.65
DEOGEN2
Benign
0.057
.;.;T;T;T;T;T;T;.;T;.;.
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.057
N
LIST_S2
Uncertain
0.90
D;.;D;D;D;D;D;D;D;D;.;D
MetaRNN
Benign
0.0028
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
.;.;L;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.51
.;.;N;.;.;.;.;.;.;.;.;N
REVEL
Benign
0.12
Sift
Benign
0.55
.;.;T;.;.;.;.;.;.;.;.;T
Sift4G
Benign
0.61
.;.;T;.;.;.;.;.;.;.;.;T
Polyphen
0.0
.;.;B;.;.;.;.;.;.;.;.;.
Vest4
0.28, 0.24
MVP
0.54
MPC
0.096
ClinPred
0.0060
T
GERP RS
3.1
Varity_R
0.098
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149055334; hg19: chr6-52288909; API